FibroBiologics Inc. Commo... (FBLG)
undefined
undefined%
At close: undefined
2.22
1.37%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -16.48M -5.12M -1.58M -1.17M
Depreciation & Amortization 437.00K 94.00K - -
Stock-Based Compensation 1.76M 265.00K - -
Other Working Capital 352.00K 307.00K 172.00K -
Other Non-Cash Items 7.39M 842.00K - -
Deferred Income Tax - - - -
Change in Working Capital 493.00K 307.00K 172.00K -
Operating Cash Flow -6.40M -4.07M -1.41M -1.17M
Capital Expenditures -495.00K - - -
Acquisitions - - - -
Purchase of Investments - - - -
Sales Maturities Of Investments - - - -
Other Investing Acitivies - - - -
Investing Cash Flow -495.00K - - -
Debt Repayment - 3.77M 1.52M -
Common Stock Repurchased - - - -
Dividend Paid - - - -
Other Financial Acitivies 13.79M 4.30M 292.00K 1.17M
Financial Cash Flow 13.79M 5.92M 1.82M 1.17M
Net Cash Flow 6.90M 1.86M 407.00K -
Free Cash Flow -6.90M -4.07M -1.41M -1.17M